首页> 美国卫生研究院文献>Pediatric Health Medicine and Therapeutics >Subacute sclerosing panencephalitis – current perspectives
【2h】

Subacute sclerosing panencephalitis – current perspectives

机译:亚急性硬化性全脑炎–当前观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Subacute sclerosing panencephalitis is a progressive neurodegenerative disease. It usually occurs 7–10 years after measles infection. The clinical course is characterized by progressive cognitive decline and behavior changes followed by focal or generalized seizures as well as myoclonus, ataxia, visual disturbance, and later vegetative state, eventually leading to death. It is diagnosed on the basis of Dyken’s criteria. There is no known cure for subacute sclerosing panencephalitis to date, but it is preventable by ensuring that an effective vaccine program for measles is made compulsory for all children younger than 5 years in endemic countries.
机译:亚急性硬化性全脑炎是一种进行性神经退行性疾病。它通常在麻疹感染后7–10年发生。临床过程的特征是进行性认知下降和行为改变,继之以局灶性或全身性癫痫发作以及肌阵挛,共济失调,视力障碍和后来的植物状态,最终导致死亡。根据戴肯的标准进行诊断。迄今为止,尚无治愈亚急性硬化性全脑炎的方法,但可以通过确保在流行国家使所有年龄小于5岁的儿童强制实施有效的麻疹疫苗计划来预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号